Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-042222

President sold 15,275 shares at $49.00 ($748,475)

  • President acquired 15,275 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-07-09 Option exercise +15,275 $0.84 $12,831 15,275 D: show line 1 in the form
RUBINSTEIN JULIE President 2020-07-09 Sale −15,275 $49.00 $748,475 0 D: show line 2 in the form
Open-market sales · 15,275 sh · avg $49.00 · $748,475

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-07-09 Option exercise · Stock Option (Right to Buy) −15,275 94,725 D: show line 3 in the form
Loading xslF345X03/doc4.xml…